Learn More
164 Background: National Comprehensive Cancer Network breast cancer guidelines suggest sequencing of systemic therapy. This study examined sequencing of endocrine and chemotherapy treatments to(More)
e16586 Background: Little is known about real-world usage of TPO-RAs and treatment patterns for patients with cITP. METHODS Using medical/pharmacy claims and enrollment data of a large US managed(More)
BACKGROUND Two previous retrospective database analyses compared early combination therapy with an α-blocker (AB) and 5-α reductase inhibitor (5-ARI) to delayed combination therapy and found that(More)
  • 1